Bloomberg: The Way Ahead

Oct 1, 2020 9:00:00 AM

Emergent BioSolutions, a Wells Fargo Corporate & Investment Banking customer since 2011, helps governments respond to health emergencies before they happen. Eight years ago, they were planning for a crisis like Covid-19. America will need hundreds of millions of doses of a vaccine. Emergent is manufacturing them now, before they've been approved for use, so they'll be ready if they measure up. 

Watch the full story here

Topics: COVID-19
Catherine Hanley

Written by Catherine Hanley

Vice President, Marketing & Customer Experience

Featured